Nifty
Sensex
:
:
18696.10
62868.50
-116.40 (-0.62%)
-415.69 (-0.66%)

Pharmaceuticals & Drugs - Domestic

Rating :
59/99

BSE: 506943 | NSE: JBCHEPHARM

2018.00
01-Dec-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 2024.90
  • 2030.00
  • 2011.90
  • 2018.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  31935
  •  645.49
  •  2150.00
  •  1342.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 15,617.42
  • 40.63
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 15,585.21
  • 0.82%
  • 6.75

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 53.96%
  • 0.68%
  • 16.94%
  • FII
  • DII
  • Others
  • 8.66%
  • 18.07%
  • 1.69%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.84
  • 11.39
  • 10.96

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.78
  • 22.20
  • 7.52

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.11
  • 22.74
  • 12.31

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.78
  • 20.41
  • 26.69

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.33
  • 3.99
  • 5.36

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.00
  • 14.26
  • 17.36

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Net Sales
809.44
593.01
36.50%
784.81
605.99
29.51%
624.59
528.46
18.19%
600.66
548.22
9.57%
Expenses
624.86
466.26
34.02%
612.05
442.30
38.38%
499.66
404.56
23.51%
472.55
377.22
25.27%
EBITDA
184.58
126.75
45.63%
172.76
163.69
5.54%
124.92
123.90
0.82%
128.11
170.99
-25.08%
EBIDTM
22.80%
21.37%
22.01%
27.01%
20.00%
23.44%
21.33%
31.19%
Other Income
1.34
19.65
-93.18%
0.89
12.97
-93.14%
2.08
25.35
-91.79%
4.53
55.95
-91.90%
Interest
7.96
1.23
547.15%
5.83
0.94
520.21%
1.62
0.69
134.78%
1.34
1.09
22.94%
Depreciation
28.13
15.74
78.72%
26.08
17.85
46.11%
22.11
16.53
33.76%
16.97
17.39
-2.42%
PBT
149.83
129.43
15.76%
141.74
157.87
-10.22%
103.28
132.02
-21.77%
114.33
208.46
-45.15%
Tax
38.75
31.54
22.86%
36.54
38.81
-5.85%
18.31
31.21
-41.33%
30.21
54.18
-44.24%
PAT
111.08
97.89
13.47%
105.20
119.06
-11.64%
84.97
100.81
-15.71%
84.12
154.28
-45.48%
PATM
13.72%
16.51%
13.40%
19.65%
13.60%
19.08%
14.00%
28.14%
EPS
14.36
12.65
13.52%
13.59
15.38
-11.64%
10.98
13.02
-15.67%
10.85
19.94
-45.59%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
2,819.50
2,424.24
2,042.52
1,774.73
1,643.20
1,413.77
1,368.32
1,231.58
1,144.21
1,021.86
866.13
Net Sales Growth
23.90%
18.69%
15.09%
8.00%
16.23%
3.32%
11.10%
7.64%
11.97%
17.98%
 
Cost Of Goods Sold
1,013.19
842.93
701.50
630.80
596.46
542.41
552.00
491.41
341.40
413.95
371.52
Gross Profit
1,806.31
1,581.31
1,341.02
1,143.93
1,046.74
871.35
816.32
740.17
802.81
607.92
494.60
GP Margin
64.06%
65.23%
65.66%
64.46%
63.70%
61.63%
59.66%
60.10%
70.16%
59.49%
57.10%
Total Expenditure
2,209.12
1,881.63
1,486.35
1,397.15
1,337.36
1,214.64
1,135.93
1,025.55
964.09
873.67
760.48
Power & Fuel Cost
-
71.47
62.60
61.54
63.29
58.28
54.89
55.28
53.02
46.61
39.75
% Of Sales
-
2.95%
3.06%
3.47%
3.85%
4.12%
4.01%
4.49%
4.63%
4.56%
4.59%
Employee Cost
-
439.24
340.60
322.92
288.18
251.10
217.34
175.31
159.56
143.67
130.05
% Of Sales
-
18.12%
16.68%
18.20%
17.54%
17.76%
15.88%
14.23%
13.94%
14.06%
15.02%
Manufacturing Exp.
-
194.00
148.68
140.70
150.49
139.83
131.45
119.35
223.53
102.44
61.75
% Of Sales
-
8.00%
7.28%
7.93%
9.16%
9.89%
9.61%
9.69%
19.54%
10.02%
7.13%
General & Admin Exp.
-
100.76
56.35
48.14
52.97
53.96
42.26
34.82
32.46
31.69
27.94
% Of Sales
-
4.16%
2.76%
2.71%
3.22%
3.82%
3.09%
2.83%
2.84%
3.10%
3.23%
Selling & Distn. Exp.
-
161.80
113.22
116.95
113.59
87.44
78.27
72.72
75.13
73.59
56.04
% Of Sales
-
6.67%
5.54%
6.59%
6.91%
6.18%
5.72%
5.90%
6.57%
7.20%
6.47%
Miscellaneous Exp.
-
71.42
63.38
76.11
72.38
81.61
59.72
76.65
79.01
61.72
56.04
% Of Sales
-
2.95%
3.10%
4.29%
4.40%
5.77%
4.36%
6.22%
6.91%
6.04%
8.48%
EBITDA
610.37
542.61
556.17
377.58
305.84
199.13
232.39
206.03
180.12
148.19
105.65
EBITDA Margin
21.65%
22.38%
27.23%
21.28%
18.61%
14.09%
16.98%
16.73%
15.74%
14.50%
12.20%
Other Income
8.84
40.07
116.62
50.90
41.44
55.29
50.16
56.65
10.89
37.70
27.87
Interest
16.75
5.12
7.24
3.26
4.65
3.49
5.37
10.65
6.82
5.93
5.28
Depreciation
93.29
72.66
68.67
66.32
55.64
56.97
47.22
41.22
38.64
28.02
24.66
PBT
509.18
504.90
596.89
358.89
286.99
193.95
229.94
210.82
145.55
151.94
103.57
Tax
123.81
118.86
148.36
76.50
93.02
55.23
45.55
49.58
45.14
25.95
24.13
Tax Rate
24.32%
23.54%
24.86%
21.93%
32.41%
28.48%
19.81%
23.52%
31.01%
29.68%
23.30%
PAT
385.37
385.36
447.96
272.04
193.47
138.34
184.06
161.14
100.41
61.50
79.44
PAT before Minority Interest
384.84
386.04
448.52
272.39
193.97
138.72
184.40
161.24
100.41
61.50
79.44
Minority Interest
-0.53
-0.68
-0.56
-0.35
-0.50
-0.38
-0.34
-0.10
0.00
0.00
0.00
PAT Margin
13.67%
15.90%
21.93%
15.33%
11.77%
9.79%
13.45%
13.08%
8.78%
6.02%
9.17%
PAT Growth
-18.36%
-13.97%
64.67%
40.61%
39.85%
-24.84%
14.22%
60.48%
63.27%
-22.58%
 
EPS
49.85
49.85
57.95
35.19
25.03
17.90
23.81
20.85
12.99
7.96
10.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
2,134.12
1,809.72
1,435.49
1,480.12
1,441.56
1,363.67
1,183.84
994.87
1,042.81
1,020.27
Share Capital
15.46
15.46
15.46
16.05
16.71
16.96
16.96
16.96
16.95
16.94
Total Reserves
2,056.01
1,794.27
1,420.03
1,464.08
1,424.84
1,346.70
1,166.87
977.91
1,025.82
1,003.22
Non-Current Liabilities
78.64
72.47
62.72
64.84
45.66
26.98
31.02
32.62
31.93
40.45
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.09
0.22
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.40
0.40
7.03
Long Term Provisions
13.73
12.57
7.39
5.73
9.67
12.56
10.43
12.03
12.19
8.23
Current Liabilities
851.86
686.57
516.19
781.54
736.50
693.46
797.22
459.75
276.27
239.48
Trade Payables
224.48
186.92
167.97
117.37
110.39
98.98
90.85
77.51
60.75
60.51
Other Current Liabilities
81.31
89.82
102.67
93.10
119.75
122.15
138.73
103.74
98.06
101.15
Short Term Borrowings
26.32
32.64
29.49
25.80
29.29
48.86
193.02
126.88
81.71
37.28
Short Term Provisions
519.76
377.17
216.06
545.27
477.06
423.47
374.61
151.62
35.76
40.54
Total Liabilities
3,069.11
2,572.47
2,016.90
2,329.30
2,226.49
2,086.29
2,013.75
1,487.24
1,351.01
1,300.20
Net Block
1,276.99
633.65
651.26
620.93
639.50
679.44
440.22
328.56
310.55
334.41
Gross Block
1,876.20
1,182.55
1,177.43
1,084.83
1,053.76
1,038.55
753.75
601.67
540.54
537.46
Accumulated Depreciation
599.21
548.90
526.17
463.89
414.25
359.10
313.53
273.11
229.99
203.06
Non Current Assets
1,326.12
678.57
740.83
740.80
717.89
879.15
831.58
586.31
370.37
356.49
Capital Work in Progress
18.68
25.57
16.17
15.09
17.40
3.76
134.89
55.17
46.36
4.81
Non Current Investment
12.72
12.91
69.45
95.88
49.96
185.84
231.42
184.83
2.75
2.99
Long Term Loans & Adv.
16.69
5.62
3.59
8.31
10.15
9.43
22.63
17.74
10.71
14.28
Other Non Current Assets
1.04
0.82
0.36
0.59
0.88
0.67
2.43
0.00
0.00
0.00
Current Assets
1,743.00
1,893.89
1,276.08
1,588.51
1,508.59
1,207.14
1,182.16
900.94
980.65
943.71
Current Investments
0.00
664.97
333.81
360.65
383.77
224.96
247.28
366.78
497.26
394.68
Inventories
409.96
347.45
274.67
243.76
213.73
200.17
187.98
150.27
134.40
104.53
Sundry Debtors
555.69
389.02
345.43
308.22
300.73
265.97
272.64
262.35
235.51
191.27
Cash & Bank
58.53
30.85
30.95
36.80
29.92
13.39
12.90
25.19
11.81
156.23
Other Current Assets
718.82
45.95
18.89
33.23
580.44
502.66
461.34
96.35
101.68
96.99
Short Term Loans & Adv.
661.39
415.66
272.33
605.85
567.50
488.30
458.83
95.97
101.48
96.84
Net Current Assets
891.14
1,207.33
759.88
806.97
772.10
513.68
384.94
441.19
704.37
704.23
Total Assets
3,069.12
2,572.46
2,016.91
2,329.31
2,226.48
2,086.29
2,013.74
1,487.25
1,351.02
1,300.20

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
170.13
314.78
275.75
194.33
122.92
201.13
140.41
126.66
-13.98
84.20
PBT
504.90
596.89
348.89
286.99
193.95
229.94
212.23
145.55
87.44
103.57
Adjustment
102.37
-46.17
7.95
23.72
16.91
13.11
-1.40
38.51
20.75
-4.40
Changes in Working Capital
-302.52
-94.21
9.70
-51.47
-47.07
5.92
-16.96
-19.52
-93.71
9.47
Cash after chg. in Working capital
304.75
456.50
366.55
259.24
163.79
248.97
193.88
164.53
14.49
108.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-134.62
-141.72
-90.80
-64.91
-40.87
-47.84
-53.47
-37.87
-28.47
-24.45
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
2.32
-230.68
23.93
-27.67
-20.68
-45.31
-27.62
-111.89
-142.50
-116.05
Net Fixed Assets
-681.80
-12.39
-94.42
-29.82
-29.56
-152.86
-187.76
-69.64
-55.43
-41.77
Net Investments
665.16
-274.62
53.26
-22.80
-22.92
67.89
-14.16
-61.38
-102.46
-95.95
Others
18.96
56.33
65.09
24.95
31.80
39.66
174.30
19.13
15.39
21.67
Cash from Financing Activity
-138.39
-87.42
-306.05
-155.74
-59.52
-183.84
-99.62
-1.39
12.04
-31.45
Net Cash Inflow / Outflow
34.07
-3.31
-6.38
10.92
42.72
-28.02
13.17
13.38
-144.43
-63.30
Opening Cash & Equivalents
22.47
25.75
32.14
21.24
-21.47
6.54
-5.46
11.81
156.23
219.53
Closing Cash & Equivalent
56.54
22.47
25.75
32.14
21.24
-21.47
9.42
25.19
11.81
156.23

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
268.04
234.17
185.75
184.47
172.50
160.77
139.57
117.31
123.07
119.21
ROA
13.69%
19.55%
12.53%
8.52%
6.43%
8.99%
9.21%
7.08%
4.64%
6.36%
ROE
19.89%
27.64%
18.69%
13.28%
9.89%
14.48%
14.80%
9.86%
5.99%
8.07%
ROCE
25.48%
36.53%
23.71%
19.59%
13.70%
16.87%
17.72%
13.49%
8.50%
10.41%
Fixed Asset Turnover
1.59
1.73
1.57
1.54
1.35
1.53
1.82
2.03
1.92
1.76
Receivable days
71.12
65.62
67.22
67.63
73.15
71.84
79.28
78.41
75.30
68.16
Inventory Days
57.02
55.59
53.31
50.81
53.43
51.77
50.12
44.83
42.16
42.80
Payable days
89.07
92.33
38.74
32.21
33.66
32.86
32.45
27.82
26.91
26.15
Cash Conversion Cycle
39.07
28.88
81.79
86.23
92.93
90.75
96.95
95.43
90.54
84.81
Total Debt/Equity
0.01
0.02
0.02
0.02
0.02
0.04
0.16
0.13
0.09
0.05
Interest Cover
99.60
83.43
108.09
62.74
56.54
43.81
20.80
22.33
15.74
20.61

News Update:


  • JB Chemicals & Pharmaceuticals gets USFDA’s nod for Venlafaxine Extended Release Tablets
    30th Nov 2022, 16:12 PM

    This product is based on OROS technology, an advanced and precision-controlled release mechanism

    Read More
  • JB Chem & Pharma - Quarterly Results
    12th Nov 2022, 10:15 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.